RG
IONS icon

Rathbones Group’s Ionis Pharmaceuticals IONS Stock Holding History

Rathbones Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,945
Closed -$393K – 418
2020
Q4 		$393K Hold
6,945
– – 0.01% 303
2020
Q3 		$330K Hold
6,945
– – 0.01% 296
2020
Q2 		$409K Hold
6,945
– – 0.01% 262
2020
Q1 		$328K Hold
6,945
– – 0.01% 238
2019
Q4 		$420K Hold
6,945
– – 0.01% 252
2019
Q3 		$416K Buy
6,945
+225
+3% +$14.7K 0.01% 250
2019
Q2 		$432K Sell
6,720
-1,680
-20% -$119K 0.01% 237
2019
Q1 		$682K Buy
+8,400
New +$542K 0.02% 197

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Rathbones Group's IONS Position: Q1 2021 in Review

Rathbones Group sold out of Ionis Pharmaceuticals (IONS) in Q1 2021, closing a stake of 6,945 shares — an estimated $393K sold.

Rathbones Group first reported a position in IONS in Q1 2019 and held it in 8 quarters. The position peaked at $682K in Q1 2019. 364 funds tracked by Wall St. Rank hold IONS as of Q1 2021.

  • Rathbones Group reported no remaining Ionis Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Rathbones Group sold 6,945 Ionis Pharmaceuticals shares in Q1 2021, an estimated $393K.
  • Rathbones Group first reported a position in Ionis Pharmaceuticals in Q1 2019 and held it in 8 quarters.
  • Rathbones Group's Ionis Pharmaceuticals position peaked at $682K in Q1 2019.
  • 364 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2021.

Based on Rathbones Group's 13F filing for Q1 2021, filed 14 May 2021.